LOS ANGELES, CA, USA I July 14, 2025 I Turn Therapeutics today announced the initiation of a randomized, double-blind, vehicle-controlled clinical trial ...

Considering dual biologic therapy for psoriasis or eczema? Get a firsthand account of navigating insurance, potential side effects, and treatment outcomes.

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

In this video, Jeff Yu, MD, MS, emphasized the importance of chronic hand eczema awareness and highlighted a study on the causes and treatments of the disease, presented at the Revolutionizing Atopic ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...

Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...

Nektar Therapeutics (NASDAQ: NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...

Researchers at Brown University’s School of Public Health found that children exposed to higher levels of triclosan may be ...

No one will ever truly grasp the horrifying, never-ending ordeal,” Jada Jones told The Post. And it can happen to anyone.

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.